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Enhanced Recovery After Surgery (ERAS) pathways were first introduced 
almost a quarter of a century ago and represent a paradigm shift in 
perioperative care that reduced postoperative complications and hospital 
length of stay, improved postoperative quality of life, and reduced overall 
healthcare costs. Gradual recognition of the generalizability of the 
interventions and transferable improvements in postoperative outcomes, led 
them to become standard of care for several surgical procedures. In this 
article, we critically review the current status of ERAS pathways, address 






It is now almost a quarter of a century since Henrik Kehlet and colleagues 
from Copenhagen, Denmark proposed a paradigm shift in perioperative care 
that reduced hospital length of stay (LOS) after laparoscopic colectomy [1]. 
Their original bundle of interventions, with further elements, has become 
known as fast-track or enhanced recovery after surgery (ERAS) pathways. 
Benefits associated with enhanced recovery pathways include reduced 
postoperative complications, reduced hospital LOS, and improved postoperative 
quality of life, as well as reduced overall healthcare costs [2,3]. Gradual 
recognition of the generalizability of the interventions and transferable 
improvements in postoperative outcomes, led them to become the standard of 
care for several surgical procedures [2,4,5]. There is also evidence of the 
potential benefits in high-risk patients, such as older adult patients, those with 
low functional reserve, or those undergoing emergency surgery [6,7]. 
In this article, we critically review the current status of ERAS pathways, 
address related controversies, and propose changes for future progress. 
Detailed discussions on several components (e.g., preoperative risk 
assessment and risk stratification, prehabilitation, carbohydrate loading, 
immunonutrition, optimal general anesthesia techniques, goal-directed 
hemodynamic management, procedure-specific pain management, patient-
related outcomes, and outcomes such as failure to rescue, and days alive 
and out of hospital are presented separately in this issue of the journal. 
 
Components of ERAS pathways and impact of compliance on outcomes 
An ERAS pathway typically includes approximately 20 interventions 
(elements or components) divided into three distinct phases e the 




contribution of individual interventions is not clear, but it is accepted that 
not all components are equally weighted with respect to their influence on 
postoperative recovery. Nevertheless, a positive link between increasing levels 
of compliance to ERAS elements and improved clinical outcomes and 
reduced hospital LOS has been well documented [8-12]. However, the 
current clinical application of the findings from these studies remains 
questionable because of rapidly changing evidence and practices. For 
example, initially recommended components lack definitive evidence and, thus, 
need to be revisited (e.g., avoidance of preoperative mechanical bowel 
preparation [MBP], preoperative com- plex carbohydrate, the use of epidural 
analgesia in minimally invasive procedures and the routine use of goal-
directed fluid therapy [GDFT]), and some procedure-specific components are 
inappropriately applied to all surgical disciplines [5]. Other confounders 
include the “Hawthorne effect” (i.e., the tendency for research participants 
to modify their behavior because they know they are being observed) and 
some interventions (e.g., the preoperative optimization of comorbid 
conditions, avoidance of prolonged preoperative fasting and adequate 
hydration during the fasting period, maintenance of normothermia, 
intraoperative antibiotic prophylaxis, nausea and vomiting prophylaxis, and 
venous thromboembolism [VTE] prophylaxis) have become the standard of 
care and are being used in the control groups. 
One of the core elements for the success of an ERAS program includes the 
use of a minimally invasive surgical approach, which is associated with 
improved short-term outcomes, including post- operative pain level and 
morbidity, as well as a reduced hospital LOS [13]. In addition, compliance with 
postoperative components is most strongly associated with improved 
recovery, although they are most difficult to achieve [14]. Of note, the lack of 
compliance with ERAS pathways may be due to inadequate knowledge, inability 
or wish to change, controversial recommendations, too many components, 





Preoperative optimization of comorbid conditions 
Because preexisting comorbidity can influence postoperative outcomes and the 
quality of recovery, preoperative identification and the optimization of 
comorbid conditions has become a standard of care [15]. Also, risk stratification 
can be used to identify patients at high risk of developing postoperative 
complications, and implement specific preoperative interventions as well as 
modify perioperative care. In addition, the assessment and treatment of 
preoperative anemia [16,17], malnutrition [18,19], and frailty [20] have been 
shown to influence postoperative outcomes, particularly in the older adult 
patients. Preoperative nutritional support has been shown to improve 
postoperative outcomes and shorten hospital LOS [18,19]. Modern 
preoperative clinics constitute interdisciplinary collaborations, including 
preoperative anesthesia and surgical assessment and global optimization as 
well as patient engagement to achieve shared decision-making [21,22]. Shared 
decision-making tools may be used to aid patient decision-making [21,23] and 
improve patient-centered outcomes [24]. 
 
Venous thromboembolism prophylaxis 
Postoperative VTE, which includes deep venous thrombosis and pulmonary 
embolism, is one of the common causes of morbidity and mortality. Therefore, 
VTE prophylaxis has been emphasized. The risks of VTE in the surgical 
population includes intrinsic patient factors, type, site and the duration of 
surgery, and postoperative immobilization. Several scoring systems that 
calculate individual risk of postoperative VTE (e.g., Caprini score [25]) have 
been validated in some surgical procedures. Several professional societies have 
published guidelines for the management of postoperative VTE [26,27]. 
However, the limitation of these guidelines is that they are developed based on 




should reduce the risk of VTE. Furthermore, with shortened hospital LOS, VTE 
may occur in days to weeks after discharge home. Unfortunately, the type and 
duration of VTE prophylaxis within ERAS pathways is not well studied. 
Nevertheless, the most recent guidelines from the American Society of 
Hematology recommend VTE prophylaxis with either mechanical prophylaxis 
using intermittent compression devices (rather than graduated compression 
stockings) alone or in combination with pharmacological prophylaxis depending 
upon the patients’ intrinsic risk of VTE, the type of surgical procedure, and the 
risk of perioperative bleeding [26]. Thus, mechanical prophylaxis alone would 
be used in patients with high bleeding risk, while a combination of mechanical 
and pharmacological prophylaxis is preferable in patients with high VTE risk 
[26]. Of note, the prophylactic placement of inferior vena cava filters is not 
recommended even in patients undergoing major surgery [26]. However, for 
patients undergoing a major surgical procedure, extended (i.e., more than 3 
weeks after surgery) prophylaxis is recommended [26]. 
 
Prehabilitation 
Prehabilitation, which includes cardiopulmonary conditioning and muscle 
strengthening, has been shown to influence postoperative recovery by 
improving functional status and reducing frailty [28]. A systematic review of 9 
studies showed that nutritional prehabilitation on its own or when 
combined with an exercise program in patients undergoing colorectal 
surgery significantly shortened the length of hospital stay by two days, and 
accelerated the return to preoperative functional capacity [29]. However, 
optimal patient- and procedure-specific approaches are lacking. 
Furthermore, its practical application remains challenging because this may 
delay surgery by approximately 4-6 weeks. Future studies are necessary to 





Patient and family education and counselling 
Patient and family education and counselling are arguably among the most 
important elements, despite the fact that they are not supported by strong 
evidence [5]. The importance of involving patients and their carers in the 
process of preparing for, undergoing and recovering from surgery cannot be 
underestimated [21]. Clear instructions on what the patient can expect and 
what is expected from them help engender a sense of responsibility and 
feeling of partnership among patients and carers. Details of the goals to be 
achieved during the perioperative period and factors which need to be met to 
achieve hospital discharge help improve clarity. A systematic review of 45 
studies found than an improved understanding, and the expectation of 
patient recovery resulted in improved healthcare outcomes [30]. Increased 
cooperation on the part of the patient can only help accelerate the recovery 
process as there is some evidence that the provision of this counselling 
reduces patient anxiety, im- proves early postoperative mobilization [31], 
postoperative pain levels, and hospital LOS. This has been further reinforced by 
a recent Cochrane review [32], which supported the role of psychological 
preparation in optimizing patients’ behavioral recovery, negative affect, and 
postoperative pain levels. 
 
Avoidance of prolonged fasting 
Prolonged preoperative fasting is frequently associated with electrolyte 
imbalance, hypoglycemia, and hypovolemia [33]. In addition, there is evidence 
that prolonged preoperative starvation results in a metabolic response, which 
leads to increased insulin resistance and an acute-phase response [33]. In a 
large cohort of children, prolonged preoperative fluid fasting was associated 
with an increased risk of postanesthetic hypotension [34]. Therefore, it is 
critical to avoid prolonged preoperative fasting and place emphasis on 




produced by a range of Anesthesia Societies have recommended a fasting 
period of two hours for clear liquids and six hours for solid foods [35]. 
However, recent evidence suggests that patients should be allowed to drink 
water if they are thirsty in the preoperative period [36-38]. Despite 




The use of preoperative carbohydrate loading remains controversial [41-44], 
despite extensive basic scientific evidence that this intervention reduces 
postoperative insulin resistance, which results in hyperglycemia, poor glucose 
uptake, and resultant glycogen storage, which can lead to muscle degradation 
[45]. A Cochrane review of 27 randomized controlled trials (RCTs) of elective 
surgical procedures, including abdominal, orthopedic, cardiac, and 
thyroidectomy found that carbohydrate loading (defined as at least 45 g of 
carbohydrates) was associated with a small reduction in hospital LOS, although 
this was based upon low-quality evidence [42]. However, there was no 
difference in postoperative complication rates when compared with either 
water or fasting. A  network  meta- analysis of 43 RCTs  undergoing elective  
surgical  procedures compared preoperative low (10-44 g) or high (45 g or 
more) dose carbohydrate with water or placebo [41]. This analysis 
demonstrated no benefit from preoperative carbohydrate loading at either 
dose when compared with water or placebo in terms of hospital LOS or 
surgical complication rate, although carbohydrate loading was associated with 
a small but significant reduction in hospital LOS versus fasting alone. However, 
a recent RCT showed that there was no difference in postoperative infective 
complications between patients given preoperative carbohydrate drinks and 
controls although those who received carbohydrate drinks required lower 
doses of insulin to control postoperative blood glucose concentrations [46]. 




However, the administration of simple cheaper sports drinks may improve 
patient satisfaction by reducing preoperative thirst and hunger. Nevertheless, 
evidence for the efficacy of the latter are currently lacking. 
 
Bowel preparation 
MBP reduces fecal bulk and bacterial colonization, thereby reducing surgical 
site infection (SSI) and anastomotic leak rates. However, concerns have been 
raised that by liquefying the feces, there is an increased risk of spillage and 
evidence suggests that bowel preparation does not result in a gross 
reduction in gut microbial flora counts. Several meta-analyses of RCTs and 
observational trials in elective colorectal surgery found that, compared with 
no preparation, MBP alone does not influence postoperative complications 
(e.g., anastomotic leak, SSI, intra-abdominal collection, mortality, 
reoperation, and hospital LOS) [47,48]. Another meta-analysis of 28 RCTs and 
12 cohort studies found that oral antibiotic preparation (OAB), either in 
combination with MBP or alone, reduced postoperative complications in 
elective colorectal surgery [49]. The authors noted that the positive benefits 
from retrospective cohort and database studies were tempered when 
evidence from RCTs alone were considered [49]. Furthermore, there was a 
need to differentiate between the benefits of combined MBP and OAB, and 
OAB alone [49,50]. Overall, the ERAS guidelines currently recommend against 
the use of routine preoperative bowel preparation in colonic surgery [51]. 
However, MBP is recommended in patients undergoing an anterior 
resection with diverting stoma [52], albeit based upon very little evidence. 
 
Shortening the duration of ileus 
Frequently, ERAS recommendations include alvimopan, a peripheral opioid 




reduce postoperative ileus, and shorten hospital LOS [53-55]. However, 
significant bias exists in the studies showing benefits including variation in the 
types of abdominal surgical procedures (e.g., bowel resection, simple and 
radical hysterectomy, and radical cystectomy) as well as approach to the 
surgical procedure (i.e., open versus laparoscopic) [56]. More importantly, all 
the studies showing benefits used very high opioid doses in the perioperative 
period, and thus the role of alvimopan in modern practice, which involves an 
opioid-sparing approach remains controversial. In addition, as alvimopan is not 
readily available outside the United States, its use is limited. 
 
Intraoperative interventions 
Intraoperative interventions that are the standard of care include antibiotic 
prophylaxis [57], lung protective mechanical ventilation (i.e., tidal volumes 6-
8 mL/kg, ideal body weight with positive end expiratory pressure 5-10 cm 
H2O) [58], the maintenance of normothermia, and glycemic control. 
 
Fast-track anesthetic technique 
Although anesthesia-related mortality is extremely low (<1:100,000 
anesthetic procedures), despite an increase in the patient comorbidity and 
surgical complexity [59], it is well recognized that anesthetic techniques can 
influence short-term and long-term morbidity, which may delay recovery. 
The use of regional anesthesia has been recommended as it is associated 
with reduced incidence of postoperative mortality, pulmonary 
complications, acute kidney injury, deep venous thrombosis, infections, and 
blood transfusion [60]. However, recommendations for regional anesthesia 
are based on low level of evidence. In addition, the general anesthetic 
technique used does not reflect current practice. Furthermore, perioperative 




Nevertheless, most major surgical procedures require the administration of 
general anesthesia. The residual effects of hypnotic sedatives, opioids, and 
muscle relaxants have been shown to in- fluence not only short-term but 
also long-term outcomes (30-day readmission rates and cognitive function). 
High intraoperative opioid and muscle relaxant doses have been shown to 
increase 30-day readmission rates. Similarly, deep anesthesia can have 
detrimental consequences in high-risk populations. Because the drugs used 
during general anesthesia have additive or synergistic effects, a minimum 
number of drug combinations should be used. Also, when possible, drugs 
should be short- acting and should be administered at the lowest possible 
doses. Thus, the routine use of midazolam as premedication is inappropriate 
because of high risk-benefit ratio. The superiority of choice of inhalation 
anesthesia versus totally intravenous anesthesia, even in high-risk 
populations, including patients with cancer, is unclear. Similarly, the role of 
opioid-free anesthesia remains controversial. In fact, there is a concern that 
the analgesic adjuncts (e.g., ketamine, dexmedetomidine, lidocaine, and 
magnesium infusions) used in opioid-free anesthesia technique may be 
detrimental to recovery. 
 
Goal-directed hemodynamic management 
In recent years, goal-directed hemodynamic management, which includes 
fluid and blood management has been emphasized [61,62]. The aim of goal-
directed hemodynamic management is to maintain adequate perfusion 
pressure and oxygen delivery. This is achieved by optimizing intravascular 
volume and the rational use of vasoactive drugs such as vasopressors and 
inotropes [63]. Of note, this approach uses both static (e.g., mean arterial 
pressure) and dynamic (e.g., stroke volume variation and pulse pressure 
variation) hemodynamic variables. Although the target mean arterial 




Initially, GDFT was considered a critical component of ERAS for all surgical patients. 
However, recent evidence has demonstrated that GDFT does not confer any 
benefits in the setting of an ERAS pathway (versus traditional care) [64-66]. The 
implementation of ERAS pathways, which emphasizes good hydration during 
the fasting period, minimal invasive surgical approach, which reduces 
intraoperative blood loss, and the early resumption of oral intake, maintains 
perioperative intravascular volume. Thus, the routine use of GDFT is 
unnecessary and can lead to unintended consequences, and increased costs. 
Thus, the use of a “zero fluid balance” approach, which includes the 
administration of low intra- operative fluid (~3 ml/kg/h balanced crystalloid 
solution) and the replacement of blood loss with crystalloids in a 1:1 or 1:1.5 
ratio, is adequate [67]. A large international, multicenter study in high-risk 
patients undergoing major abdominal surgery concluded that although 
restrictive fluid regimen did not influence postoperative disability-free 
survival, it was associated with higher incidence of acute kidney injury [68]. 
However, this study is limited due to its pragmatic design and associated 
variability in perioperative care, including variability in anesthetic techniques 
(e.g., hemodynamic management, the use of regional anesthesia, and opioid 
dose), surgical care, elective and emergency surgery, and postoperative 
nursing care and physical therapy [69]. Overall, the use of GDFT is 
appropriate in high- risk patients undergoing major invasive (open) surgical 
procedures. The areas that remain deficient include the implementation of 
optimal perioperative anemia and blood transfusion management. 
 
Nausea and vomiting prophylaxis 
It is well documented that postoperative nausea and vomiting (PONV) 
adversely impacts upon postoperative outcomes, including reduced ability 
of the patient to comply with the postoperative goals of an ERAS program 
such as early oral intake and ambulation [70]. However, PONV continues to be a 




models are poorly implemented. Strategies to prevent and treat PONV include 
pharmacological and nonpharmacological measures. For routine multimodal 
antiemetic prophylaxis patients should receive two to three anti-emetics 
from different classes either preoperatively or intraoperatively [71]. Patients 
at very high-risk (e.g., the history of motion sickness, history of previous 
PONV, and high opioid requirements after surgery) should receive three to 
four antiemetics. In addition, baseline risk may be reduced with the use of 
total intravenous anesthesia and adequate hydration [72]. 
Preoperative PONV prophylaxis would include scopolamine transdermal 
patch (1-3 h prior to surgery) or aprepitant 40 mg orally (1-3 h prior to 
surgery), while intraoperative options include dexamethasone 8-10 mg IV at 
the induction of anesthesia, dopamine D2 antagonist (droperidol 0.625-1.25 
mg IV) at the end of surgery, and serotonin 5-HT3 antagonist (ondansetron 4 
mg IV or palonosetron 0.75 mg IV) at the end of surgery. In addition to 
antiemetic effects, dexamethasone has analgesic and anti-inflammatory 
effects that can facilitate recovery, and thus has been increasingly included 
in ERAS pathways. Of note, a single intravenous dose of dexamethasone (8-10 
mg) does not seem to influence wound infection and healing [73-75]. 
Rescue PONV in the recovery room could include an antiemetic of a class not 
administered pre- operatively or intraoperatively or promethazine 6.25 mg IV. 
On the wards, ondansetron (4 mg IV or 8 mg orally disintegrating tablet [ODT]), 
promethazine 6.25-12.5 mg IV, prochlorperazine 2.5-5 mg IV, or dimenhydrinate 
25-50 mg IV could be administered. There is no benefit of repeating the same 
antiemetic administered intraoperatively. Post-discharge nausea and vomiting 
may be treated with ondansetron 8 mg ODT or over the counter antiemetics 
such as meclizine and dimenhydrinate. Of note, the cost-effectiveness of 
second generation antiemetics such as 5-HT3 antagonists, NK1 antagonists, and 





Procedure-specific pain management 
Patient- and procedure-specific pain management is a critical component of an 
ERAS pathway. The preoperative identification of patients at high risk of 
postoperative pain is important [76,77]. Opioid- sparing multimodal 
analgesia improves outcomes by reducing the risks of opioid-related 
adverse events such as nausea, ileus, respiratory depression, sedation, and 
delirium [78]. Also, the choice of an analgesic technique would depend upon 
the balance between the invasiveness of the analgesic technique and 
consequences of pain as well as adverse event profile of the intervention 
[79]. Importantly, the primary aim should be to facilitate ambulation, rather 
than achieve a certain pain score. 
Unless there are contraindications, paracetamol and nonsteroidal anti-
inflammatory drugs (NSAIDs) or cyclooxygenase-2 specific inhibitors should 
be administered preoperatively or intraoperatively, and continued into the 
postoperative period. In addition, a single intraoperative dose of 
dexamethasone 8e10 mg IV is recommended. Furthermore, regional/local 
anesthetic techniques should be used when possible. However, the role of 
neuraxial blocks in the ERAS setting is decreasing because of concerns of 
adverse events that might delay ambulation and availability of alternative 
analgesic techniques that can provide similar pain relief as well as similar 
recovery outcomes. Peripheral regional analgesic techniques such as 
interfascial plane blocks and surgical site infiltration techniques are 
recommended due to their high success rate and minimal adverse effects 
[80-82]. 
A recent meta-analysis concluded that intravenous lidocaine infusions 
reduce pain and opioid requirements as well as hasten gastrointestinal 
recovery [83]. Thus, intravenous lidocaine infusion is recommended in 
patients undergoing abdominal surgery with contraindications to 
commonly used analgesics (e.g., paracetamol and NSAIDs). However, the role 




benefits over basic analgesics (i.e., paracetamol and NSAIDs) are un- clear, and 
there are concerns of adverse effects such as nightmares and sleep 
disturbances. Similarly, the role of gabapentinoids (i.e., gabapentin and 
pregabalin) is controversial due to limited benefits [84] and potential for 
adverse effects such as sedation, dizziness, visual disturbances, and orthostatic 
hypotension [85,86]. Nevertheless, when gabapentinoids are used (e.g., surgical 
procedures with a high propensity of persistent postoperative pain), they 
should be used with great caution and at the lowest possible dose. After 
discharge home, acetaminophen (paracetamol) and NSAIDs or 
cyclooxygenase-2 selective inhibitors should be used on a regular “round-
the-clock” or “scheduled” basis. Opioids may be used as “rescue” analgesics 
on an “as needed” basis rather than on a scheduled basis. Patients should 
also be educated about nonpharmacological ways of alleviating 
postoperative pain, such as the application of ice, elevation of the operated 
extremity, music, and cognitive behavioral modalities. 
 
Postoperative interventions 
Early oral nutrition and avoidance of salt and water overload 
Early postoperative oral nutrition is important for enhanced recovery, and it 
is safe and well tolerated with the exception in those patients with delayed 
gastric emptying [87]. It is also critical to avoid postoperative fluid overload. 
In addition, the choice of crystalloid (0.9% saline vs. balanced electrolyte 
solutions) also influence postoperative outcome. Salt and water overload of 
more than 2.5 L and excess 0.9% saline, resulting in a hyperchloremic 







Early mobilization as an individual factor has not been extensively 
investigated; however, it has long been recognized to improve pulmonary 
function, improved gastrointestinal function, reduced VTE, and the loss of 
muscle mass and function. The inability to mobilize after elective surgery may 
be a reflection of poor postoperative pain control, PONV, orthostatic 
intolerance, postoperative morbidity, continuous dependence on 
intravenous fluids or a lack of patient motivation. This raises the issue 
whether the superior clinical outcomes associated with early mobilization may 
be due to the effects of the interventions. 
 
Summary 
ERAS pathways are increasingly being embraced as they allow the 
standardization of perioperative care and improves perioperative outcomes. A 
multidisciplinary approach (e.g., collaboration between anesthetists, 
surgeons, perioperative nurses in the hospital, and community nurses after 
discharge) is necessary to ensure high compliance rates and achieve 
maximum benefits [96]. Conflicting recommendations may be a major factor 
for the lack of implementation or patchy implementation of ERAS pathways. 
Although evidence for components of ERAS pathways continue to evolve, some 
are accepted as dogma without adequate evidence of their efficacy, and in 
some cases evidence suggests that they are not beneficial at all or even 
deleterious to outcomes. However, in a day-to-day practice level this is likely 
lost, and all components are regarded as compulsory, irrespective of the 
evidence for their use. Of note, ERAS by its very definition is complex pathway 
requiring multidisciplinary, multimodal interventions, and as such it  would be 
difficult, if not impossible, to  investigate  each individual intervention, even 
with a cluster trial. This has led to the question of identification of the  most 




“partial ERAS,” where institutions could choose interventions that suit them 
and are easy to implement, when compared with the more complex 
interventions, is valid. However, small gains over a select number of clinical 
factors may result in a significant improvement in clinical outcome for the 
patient. This is described in the concept of “the aggregation of marginal 
gains,” which suggests that even small (1%) improvements in performance in 
each of a multitude of different areas would add up to a marked overall 
improvement [97]. 
Although the ultimate goal is to minimize postoperative organ dysfunction and 
enhance recovery, it is necessary to address the early identification and 
management of complications in the hospital (i.e., failure to rescue) as well as 
after discharge from the hospital (i.e., days alive and out of hospital). Finally, 
measuring compliance with ERAS elements through an audit program is 
essential to evaluate success and in form the need for protocol modification. 
Although hospital LOS and readmission rates are commonly used to define 
success of an ERAS pathway, they do not reflect the true recovery of a patient, 
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